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Abstract
Dengue is caused by any of the four serotypes of dengue virus (DENV-1 to 4). Each serotype is genetically distant from the
others, and each has been subdivided into different genotypes based on phylogenetic analysis. The study of dengue
evolution in endemic regions is important since the diagnosis is often made by nucleic acid amplification tests, which
depends upon recognition of the viral genome target, and natural occurring mutations can affect the performance of these
assays. Here we report for the first time a detailed study of the phylogenetic relationships of DENV-2 from Central America,
and report the first fully sequenced DENV-2 strain from Guatemala. Our analysis of the envelope (E) protein and of the open
reading frame of strains from Central American countries, between 1999 and 2009, revealed that at least two lineages of the
American/Asian genotype of DENV-2 have recently circulated in that region. In occasions the co-circulation of these lineages
may have occurred and that has been suggested to play a role in the observed increased severity of clinical cases. Our time-
scale analysis indicated that the most recent common ancestor for Central American DENV-2 of the American/Asian
genotype existed about 19 years ago. Finally, we report positive selection in DENV-2 from Central America in codons of the
genes encoding for C, E, NS2A, NS3, and NS5 proteins. Some of these identified codons are novel findings, described for the
first time for any of the DENV-2 genotypes.
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Introduction
Dengue, the most common arboviral disease in the world, is caused
by any of the four serotypes of dengue virus (DENV-1 to 4), genus
Flavivirus,f a m i l yFlaviviridae. DENV is transmitted in its urban cycle
through the bite of mosquitoes from the genus Aedes,m a i n l yAedes
aegypti. DENV RNA encodes 3 structural (Capsid, C; pre-Membrane/
Membrane, prM/M and envelope, E) and 7 non-structural proteins
(NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) [1]. The four
DENV are genetically distant from each other and form a number of
subtypes (or genotypes) that vary from serotype to serotype [2]. For
DENV-2, there are five epidemic genotypes: Asian I (AS-I), Asian II
(AS-II), American/Asian (AM/AS), Cosmopolitan (COS) and Amer-
ican (AM), and a sylvatic genotype restricted to strains collected from
forests in Africa and South East Asia [3,4,5].
DENV was first isolated in the Americas in 1953 and the disease
has been present in Central America since 1978, when epidemics
caused by DENV-1 were reported in Belize, Guatemala, El
Salvador and Honduras [6]. Central America is the isthmian
portion of the American continent constituted by Belize, Costa
Rica, Guatemala, Honduras, El Salvador, Nicaragua and
Panama. That region is epidemiologically dynamic for dengue,
where transmission of the four DENV serotypes occurs. It has
been suggested that this dynamic involves an active cycle of
exchange of viral strains between South and Central America and
the Caribbean [2,7,8]. Dengue is hyperendemic in Central
America as well as in most of the countries of the continent,
especially after the re-introduction of DENV-3 in the 90s [9].
Between 1999 and 2010, more than 700,000 cases of dengue have
been reported in Central America, .24,000 of which correspond
to severe dengue (formerly, dengue hemorrhagic fever) with 468
fatalities, according to data submitted by the countries to the Pan
American Health Organization [10] (Figures S1, S2, and S3).
A plethora of phylogenetic studies focused on the evolution of
DENV-2 in the Americas have been reported [2,7,8,11,12,13,14];
however, to date no studies have been conducted to analyze the
evolutionary aspects of DENV-2 in Central America during the
last decade. In this paper, we describe the first fully sequenced
DENV-2 from Guatemala, and report the first phylogenetic
analyses performed on all available sequences of strains of DENV-
2 from countries of Central America, using Maximum likelihood
and Bayesian approaches. Our phylogenetic analyses demonstrate
that in recent years the circulation of two different lineages of
DENV-2 of the AM/AS genotype occurred in the countries of the
region. We also discuss, for the first time, aspects on the
evolutionary time-scale and selection pressure analysis of circulat-
ing DENV-2 in Central America during a period of high dengue
activity in the region (1999-2009).
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Ethics statement
In this study we used an unlinked leftover specimen that had
been collected for laboratory diagnosis, which was made available
to us by Dr. Morales-Betoulle for further virological studies. That
was considered exempt from written approval by the Institutional
Review Board of the FDA (Human Subjects Research - Exempt
RIHSC Protocol #127B).
DENV isolation and detection
For viral detection, we extracted RNA from plasma of a
Guatemalan patient with symptomatology of dengue. An aliquot
of plasma was also inoculated into C6/36 cells to attempt viral
isolation. Viral RNA from plasma or cell culture supernatants was
extracted using the QIAamp Viral RNA kit (Qiagen, Gaithers-
burg, MD) and a DENV serotype-specific quantitative RT-PCR
assay (TaqMan) was performed with the RNA-to-Ct 1-step kit in a
7300 Real-Time PCR System (Applied Biosystems, Foster City,
CA), following the protocol of Johnson et al. [15]. Results are
expressed as PCR detectable units (PDU)/mL.
Sequencing and phylogenetic analysis of isolated DENV
The entire viral genome of the second passage in C6/36 cells of
the isolate termed GU/FDA-GUA09/2009 was amplified by PCR
using the One-Step RT-PCR kit (Qiagen) and DENV specific
forward and reverse primers, generating 11 overlapping fragments
that covered the full genome. The PCR products were purified
with the QIAquick PCR purification kit (Qiagen) and sequenced
using the BigDye terminator chemistry version 3.1 (Applied
Biosystems). The sequences of the 59 and 39 untranslated regions
of DENV-2 were determined following viral RNA ligation and
PCR amplification essentially as described elsewhere [16].
Sequencing reactions were performed on a 3730 DNA analyzer
(Applied Biosystems), and the sequences of overlapping fragments
were assembled, evaluated and annotated using the software
Sequencher, version 4.8 (GeneCodes Corp., Ann Arbor, MI). The
full genome sequence of strain GU/FDA-GUA09/2009 was
submitted to the GenBank under accession no. HQ999999.
To study the phylogenetic relationships of circulating DENV-2
from Central America, all available sequences from countries of
that region were retrieved from the GenBank database. Two
datasets were prepared and trees were constructed with the
sequences of the E protein gene (1,485 nt), n=119; and the
complete open reading frame (ORF) of the virus (10,173 nt),
n=158; through Maximum-likelihood (ML) and Bayesian ap-
proaches. Sylvatic strains were used as outgroup to root the trees.
The selected Central American strains and additional represen-
tative strains collected worldwide from 1944 to 2009, belonging to
each of the six DENV-2 genotypes were included and aligned
using ClustalX (Table S1). Strains used in this study are presented
in the following format: two letters ISO country code/strain
name/year of isolation.
The ML analysis was conducted in MEGA5 [17] and the best
substitution model obtained from that program was compared
with that obtained with the program jModelTest [18]. Bayesian
information criterion (BIC) was used to determine the model of
nucleotide substitution that best fit the data for each of the subsets
analyzed. For the E protein gene analysis, the best fit model was
the Tamura-Nei model+C (TN93+C) and for the ORF, the
General Time Reversible (GTR) substitution model with 4
categories of C distributed rates plus invariable rates in the rest
of the sites (GTR+C4+I). A bootstrap of 1,000 replicates was used
as test of phylogeny.
For each dataset, an additional phylogenetic analysis was
undertaken using the Bayesian inference method implemented in
the program MrBayes v3.1.2 [19]. For the substitution model, the
GTR+C4+I model with successive branch swapping was used. Five
Markov Chain Monte Carlo (MCMC) chains were run for
10,000,000 generations, sampling every 100 generations, with the
first 10,000 sampled trees discarded as burnin. Finally, a 50%
majority rule consensus tree was constructed from the posterior
distribution of trees.
Natural selection analysis
To assess the selection pressures acting on the codons of the
ORF and E protein gene regions of the analyzed DENV-2 strains
from Central America, four datasets were prepared, two for the
ORF (n=67 and 143) and two for the E protein gene (n=24 and
75) (Table S1). We used the HyPhy package under the
Datamonkey web-server (www.datamonkey.org) [20]. The v
ratios (dN/dS) were calculated using five different likelihood
approaches for each of the four datasets: the single-likelihood
ancestor (SLAC), Fixed-effects likelihood (FEL), internal branch
Fixed-effects likelihood (IFEL), random-effects method (REL), and
the partitioning approach for robust inference of selection
(PARRIS). For all the methods, GTR model was used as
nucleotide substitution bias model, trees were inferred by the
neighbor-joining method and significance levels set to p,0.1 or
Bayes factor .50.
Molecular dating analysis
To determine the Time to the Most Recent Common Ancestor
(TMRCA) for the analyzed sequences of DENV-2, we used the
same dataset of E protein gene sequences employed for the
phylogenetic analysis without including the sylvatic strains
(n=115) (Table S1). The rate of nucleotide substitution and
TMRCA for DENV-2 strains of Central American origin, as well
as for all other genotypes, were calculated by using the Bayesian
MCMC approach employed by BEAST ver. 1.6.1 [21]. The data
was analyzed using the GTR+C4+I model, using both strict and
relaxed uncorrelated lognormal molecular clocks. Bayesian
coalescent prior and constant population size tree priors were
used to describe the DENV-2 demographic history. Five
independent MCMC analyses, each for 10,000,000 steps, were
performed for each branch rate model and combined with a
burnin value set to 10% generations. The maximum clade
credibility tree (MCC) was generated for each model. The 95%
highest posterior density (95%HPD) intervals were obtained to
ascertain the uncertainty in the parameter estimates.
Results
DENV-2 isolation and nucleic acid test results
We detected and isolated DENV from a sample of plasma
from a suspected case of dengue from Guatemala. The patient
was clinically diagnosed with dengue fever during the outbreak
of 2009 and DENV RNA was detected from the blood sample
by TaqMan. DENV-2 was identified as the infecting serotype
with RNA titers in plasma of 1.29610
6 PDU/mL. Plasma was
used to infect mosquito C6/36 cells and cytopathic effect,
consisting of formation of syncytia and rounding and detachment
of the cells from the culture flask was detectable at day 7 and
peaked at day 12 post-infection (data not shown). The complete
genome of the strain GU/FDA-GUA09/2009 was sequenced,
and constitutes the first fully sequenced strain from Guatemala
reported to date.
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To study the phylogenetic relationships between the strains of
DENV-2 circulating in Central America, a search for strains from
its constituent countries was conducted in the GenBank database.
From Central America, most of the DENV strains deposited in the
database were from Nicaragua, from where we retrieved a total of
181 complete genome sequences of DENV-2 spanning from 1999
to 2009. Phylogenetic analyses were performed using the ORF
and E protein gene datasets including 141 and 78 Nicaraguan
sequences, respectively, after removal of identical sequences. From
the remaining countries, only two fully sequenced strains of
DENV-2 were available for analysis; one from Belize (BZ/BID-
V2952/2002) and our reported strain from Guatemala (Table S1).
The E protein gene dataset (n=119), included selected Nicar-
aguan strains (n=78), and sequences from Belize, Costa Rica, El
Salvador, Guatemala, Honduras and 2 Mexican strains (MX/
12021-Oxkutzcab 01/2001 and MX/13381-Chochola 02/2002)
collected from the State of Yucatan [12]. Sequences from Yucatan
were included due to the close proximity of this Mexican state to
Guatemala. For both datasets (E and ORF) strains from the
Caribbean and South America from the 80s and 90s (JM/N.1409/
1983, MQ/98-703/1998, CO/PTCOL/1996, and VE/
lard3146/1999) were included in the analyses (Table S1).
Analysis of the consensus ML tree built with the nucleotide
sequences of the ORF DENV-2 isolates of Central American
origin and representative strains from other regions, allows for the
segregation of the five known epidemic genotypes of the virus
supported by both ML high bootstrap support values and Bayesian
posterior probabilities. Sylvatic strain GN/PM33974/1981 was
used as an outgroup to root the tree (Figure 1A and 1B). The tree
topology obtained with this analysis of the coding region is
consistent with what has been reported previously in the literature
[22]. Analysis of this tree enabled us to identify two different clades
within the strains of the AM/AS genotype that have been
circulating in the Americas: clade 1 at the bottom of the sub-tree
and constituted in this analysis by older isolates from Jamaica,
Colombia and Venezuela, and clade 2, that includes the
remaining strains (strain MQ/98-703/1998 from Martinique
and all the Central American strains: the analyzed Nicaraguan
strains and the strains from Belize BZ/BID-V2952/2002 and
Guatemala GU/FDA-GUA09/2009). Clade 2 can be further
divided into two sub-clades termed here sub-clades 2a and 2b
(Figure 1B).
The phylogenetic tree generated with the ORF sequences also
allows for the identification of a temporal-spatial distribution of
DENV-2 strains from Nicaragua clustering in both sub-clades 2a
and 2b, in which viruses from each of the two sub-clades have co-
circulated with members of the other at least since 2005.
Unfortunately, there are only a few DENV-2 sequences from
2004 and no sequences from 2003 from Nicaragua available in the
database to allow for the understanding of the evolutionary
scenario that has driven the appearance of these two lineages of
DENV-2 of AM/AS genotype in the region around that time.
Since most sequences from other countries of Central America
were from the E protein gene or the three structural genes (i.e. C-
prM/M-E), we performed a phylogenetic analysis of E protein
gene sequences with these strains. The consensus trees from the
phylogenetic analysis obtained by ML and Bayesian methods also
show the typical distribution of DENV-2 into its known genotypes
with high bootstrapping support values. Similar topology exists
between the trees generated with the ORF and E protein gene
sequences; i.e. the two sub-clades of the AM/AS genotype
identified in the tree generated with ORF sequences were also
observed in the tree obtained with sequences of the E protein gene
alone.
In the case of the E protein gene, within clade 2a we found
clustered strains from Mexico and all countries of Central America
included in the analysis (i.e. Belize, El Salvador, Costa Rica,
Guatemala and Nicaragua), except for Panama that had no
sequence available for study. Within clade 2a, two groups can be
identified which are temporarily-associated: at the base of the tree,
group 2a.I which includes the oldest DENV-2 sequences from
Central America available for this analysis (from Nicaragua strains
NI/BID-V2683/1999, NI/BID-V2666/2000 and NI/BID-
V2361/2001, strain ES/18 99/1999 from El Salvador, strain
BZ/BID-V2952/2002 from Belize and the two Mexican strains
from Yucatan included (MX/12021/Oxkutzcab/2001 and MX/
13381/Chochola/2002), and a recent strain from Guatemala
(GU/F07-030/2007). The second group (2a.II) is constituted
exclusively by Nicaraguan strains collected in the period 2004–
2009.
The other sub-clade (clade 2b) also forms two groups: 2b.I,
formed by recent strains from Nicaragua, Honduras and the strain
here described as GU/FDA-GUA09/2009 from Guatemala, and
group 2b.II, constituted exclusively by Nicaraguan strains
(Figure 1B). Strain NI/BID-V2924/2000 is located at the base
of clade 2b suggesting its possible role as a representative of the
origin of this clade (Figures 1B and 2B). As can be seen in Figure 2,
the two Guatemalan strains in the analysis (GU/F07-030/2007
and GU/FDA-GUA09/2009) clustered in different clades (2a and
2b, respectively), suggesting that these two lineages of DENV-2
have been circulating in recent times in Guatemala.
On the other hand, Nicaraguan strains are temporal and
spatially spread between clades 2a and 2b. Strains collected prior
to 2005 tend to cluster in clade 2a, while strains collected after
2005 cluster in either sub-clade 2a and 2b. That observation
suggests that different lineages of DENV-2 have circulated in
Nicaragua in the recent past, and both clades have co-circulated
there during the last decade epidemics (Figure 2B). Due to the
paucity of availability of DENV-2 strains from other countries of
Central America it is hard to speculate whether the evolutionary
scenario of DENV-2 in those countries have been similar to that
observed for Guatemala and Nicaragua.
The Caribbean is believed to play an important role in the
circulation of DENV-2 strains, with importations and exportations
occurring from and to Central and South America [2,7,8,11]. To
further help in understanding DENV-2 evolutionary dynamics
through the region, we performed a phylogenetic analysis of the
ORF of 170 DENV-2 strains (Table S2) using both ML and
Bayesian approaches. This analysis, included the same dataset of
Central American strains used in our analysis of the ORF plus
strains from the Caribbean and South America that were reported
by McElroy et al [7]. Analysis of this tree revealed that clade 1 of
our classification included most of the strains from Puerto Rico
(13/16), along with the Brazilian strain BR64022 from 1998, and
two strains from the US Virgin Islands (strains BID-V2946 and
BID-V2948, from 1987 and 1990, respectively). The clade 2 of our
classification included Puerto Rican strains BID-V1032/1998,
BID-V600/2005 and BID-V595/2006, strain BID-V2960/2005
from the US Virgin Islands, and the strains from Dominican
Republic, Saint Kitts and Nevis, and Cuba. Those are closely
related to strain MQ/98-703/1998 from Martinique, and distant
to the DENV-2 strains from Central America (Figure S4),
altogether suggesting that in situ evolution had happened in
Central America and the Caribbean after introduction of the AM/
AS genotype in that region.
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of DENV-2
Dengue epidemic transmission cycle is complex, and involves
two different types of host: the invertebrate vector (Aedes sp.) and
the human host. Under the pressure applied by these two different
environments, strains of DENV with higher fitness to successfully
adapt to these challenges are subjected to natural selection [23].
To study the selection pressure exerted over DENV-2 in Central
America, two datasets for the E protein gene (n=24 and n=75)
and two for the ORF (n=67 and n=143) (Table 1), where
analyzed by the FEL, IFEL, REL, SLAC and PARRIS methods.
In the case of the FEL, IFEL, SLAC and PARRIS codons with p
values #0.1 were considered under positive selection, and for REL
a Bayes factor $50 was considered positive.
Low v ratios (0.05–0.09) obtained from these approaches
suggest that codons in DENV-2 from AM/AS genotype from
Central American origin are under strong negative selection, as
previously pointed for this and other genotypes of DENV-2
[24,25,26]. Our analysis of selection in ORF sequences of DENV-
2 of the AM/AS genotype has involved the higher number of
analyzed sequences in comparison with all the previous analyses
published on the subject to date [27]. In general terms, we found
that the ability of the employed approaches to identify codons
under positive selection will greatly depend on the number of
sequences available for the analysis. Differences in the size of
datasets studied for E and ORF sequences of DENV-2 of AM/AS
genotype rendered different sites subjected to positive pressure.
In the two E protein gene datasets, two codons were found to be
under weak positive pressure, only by the IFEL method: E131 in
the n=24 dataset, v=149.33, p=0.06 and E83 in the n=75
dataset, v=49.05, p=0.08. Codon E83 had a FEL p value of 0.11,
which is close to the established significant threshold of 0.1
Figure 1. Maximum Likelihood (ML) consensus of the open reading frame (ORF) of DENV-2. A) Consensus ML tree constructed with the
ORF of representative sequences of all DENV-2 genotypes. DENV-2 genotypes (Sylvatic, American, Asian I and II, Cosmopolitan and American/Asian)
are identified. Strains from the American/Asian genotype are shown collapsed. B) Detail of A showing the cluster of the American/Asian genotype
constituted by 141 Nicaraguan strains, and one strain each from Guatemala, Belize and Martinique. Names of each clade and sub-clade are shown, as
well as the years of circulation for the sub-clades. Similar sequences at the top of clades 2a and 2b are shown collapsed. Groups I and II within sub-
clades 2a and 2b are shown highlighted in a gray and orange shadows. Consensus trees were generated by ML and Bayesian methods. Bootstrap
support values of 1,000 replicates using the ML model of evolution and Bayesian posterior probability values are shown in blue above node. Only
bootstrapping values .80 are shown. Branch lengths are proportional to the bar and represent the number of nucleotide substitutions between the
analyzed viruses. Amino acid changes found in different DENV-2 proteins associated with the different sub-clades are shown and identified in the tree
with numbers (1–3) in red.
doi:10.1371/journal.pone.0027459.g001
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REL, SLAC and PARRIS methods for these two datasets using
the defined p value and Bayes factor threshold.
In the two ORF datasets analyzed, we were able to find codons
under positive pressure depending on the number of strains
analyzed in each dataset. In the dataset of 67 strains, we found
seven codons under weak positive pressure in the C (codon 41,
IFEL v=61.71, p=0.09), E (codon 83, IFEL v=77.77, p=0.07,
and codon 129, FEL v=37.27, p=0.09), NS3 (codon 180, IFEL
v=78.17, p=0.07, and codon 437, v=81.46, p=0.07) and NS5
proteins (codon 523, detected by both FEL and IFEL methods
v=64.46 and 98.23, p=0.04 and 0.06, respectively). All the
codons detected by IFEL had FEL p values close to the threshold
of 0.1 (Table 1). As with the E protein gene datasets, REL and
PARRIS failed to find codons under positive pressure in the ORF
datasets.
Four codons under weak positive pressure were found in the
dataset of 143 strains, one in the NS2A (codon 2, FEL v=28.89,
p=0.06) and three in NS5 gene (codon 269, FEL v=34.91,
p=0.05, codon 523, FEL v=44.70, p=0.03 and IFEL v=39.94,
p=0.09; and codon 850, IFEL v=30.81, p=0.09. As for the 67
strains dataset, the only codon detected by both the FEL and IFEL
methods was NS5523. REL and PARRIS analyses were not able to
be conducted on the 143 strains dataset due to the limit of
sequences allowed by the Datamonkey server. For both ORF
datasets (i.e. n=67 and n=143), no codon under positive pressure
was detected by the SLAC method, when using the pre-established
significance threshold at p,0.1. Results of the SLAC method are
shown for the sites detected by FEL and/or IFEL methods for the
two ORF datasets (Table 1).
Molecular clock analysis
In order to better understand the epidemiological scenario
responsible for the replacement process that DENV-2 underwent
in Central America (i.e. substitution of the autochthonous AM
genotype with the emergence and endurance of the AM/AS
Figure 2. Maximum Likelihood (ML) consensus tree of the Envelope protein gene of DENV-2. A) The phylogenetic relationships between
members of all DENV-2 genotypes based on the sequences of the Envelope protein gene. DENV-2 genotypes (Sylvatic, American, Asian I and II,
Cosmopolitan and American/Asian) are identified. B) ML tree showing in details the relationships between Central American and Mexican isolates
collected between 1999 and 2009. Similar sequences at the top of clades 2a and 2b are shown collapsed. A red circle and a yellow star denote strains
GU/FDA-GUA09/2009 and GU/F07-030/2007, respectively. Consensus trees were generated by ML and Bayesian methods. Bootstrap support values of
1,000 replicates using the ML model of evolution and Bayesian posterior probability values are shown above and below each node. Only
bootstrapping values .80 are shown. Branch lengths are proportional to the bar and represent the number of nucleotide substitutions between the
analyzed viruses.
doi:10.1371/journal.pone.0027459.g002
Molecular Evolution of DENV-2 in Central America
PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e27459genotype), we performed a time-scale analysis to know the Time to
the Most Recent Common Ancestor (TMRCA) for the AM/AS
genotype of DENV-2 that has been circulating in Central America
in the recent past. The results of the molecular clock analysis of E
gene sequences of DENV-2 are shown in Table 2. An extended
version of this Table including the Effective Sample Size (ESS) for
the studied parameters can be found in Table S3.
The results revealed that the best fitted model was the relaxed
lognormal clock model and Bayesian coalescent prior analysis.
Under this model, the mean substitution rate was about 7.46610
–4
substitutions/site/year, with 95%HPD of 6.32–8.68610
–4 substi-
tutions/site/year. The MCC tree generated under the best fit
model and the Bayesian Skyline (BS) plot analysis for Central
American DENV-2 strains of AM/AS genotype are shown in
Figure 3. The TMRCA for all genotypes (excluding sylvatic
strains, n=115) was between 105 and 138 years, mean of 121
years, which is congruent with previous findings [10]. In the case
of the AM/AS genotype, the TMRCA appears to have only
existed recently, around 32 years ago (95% HPD: 27–36). Between
clades 1 and 2 of the AM/AS genotype, the TMRCA was about
Table 1. Selection pressure analysis of the open reading frame (ORF) (3391 codons) and E protein gene (495 codons) datasets of
DENV-2 from Central America, using the FEL, IFEL and SLAC methods employed in the Datamonkey server (www.datamonkey.org).
Dataset Codon Protein and amino acid residue FEL IFEL SLAC
v P value v P value v P value
E (n=24)
131 E131 36.11 0.22 149.33 0.06 0.25 0.53
E (n=75)
83 E83 25.35 0.11 49.05 0.08 0.52 0.50
ORF (n=143)
1129 NS2A2* 28.89 0.06 20.00 1 1.90 0.34
2760 NS5269* 34.91 0.05 34.23 0.11 1.90 0.34
3014 NS5523 44.70 0.03 39.94 0.09 1.98 0.30
3341 NS5850 10.28 0.23 30.81 0.09 1.17 0.39
ORF (n=67)
41 C41** 15.79 0.29 61.71 0.09 0.07 0.67
363 E83** 19.92 0.24 77.77 0.07 0.07 0.69
409 E129** 37.27 0.09 20.00 1 0.22 0.30
1655 NS3180** 20.04 0.24 78.17 0.07 0.07 0.70
1912 NS3437** 20.90 0.24 81.46 0.07 0.07 0.67
3014 NS5523 64.46 0.04 98.23 0.06 0.22 0.30
3341 NS5850 16.49 0.23 65.91 0.06 0.13 0.37
Sites found under positive selection by two methods are shown in bold, while sites found by only one method but with other method close to the significance
threshold value are shown in italics.
*Site only detected in the ORF dataset, n=143.
**Site only detected in the ORF dataset, n=67.
doi:10.1371/journal.pone.0027459.t001
Table 2. Molecular clock analysis of DENV-2 from all genotypes used in the study without including sylvatic strains.
Model
Prior
(mean)
Posterior
(mean)
Marginal
likelihood
(mean±stderr)
Substitution rate mean (10
–
4 substitutions/site/year
[95%HPD]) TMRCA (mean no. of years [95%HPD])
Bayesian coalescent
pior:
All
Genotypes
(root age)
AM/AS
genotype
AM/AS
genotype,
clade 2
AM/AS
genotype,
clade 2b
GTR+C+I, relaxed
lognormal clock
2538.11 28018.52 27480.41±0.34 7.46 (6.32–8.68) 121 (105–
138)
32 (27–36) 19 (15–22) 11 (9–12)
GTR+C+I, strict clock 2548.27 28030.81 27482.5360.35 7.58 (6.43–8.79) 119 (104–135) 31 (27–35) 18 (15–22) 11 (9–13)
Constant size:
GTR+C+I, relaxed
lognormal clock
2538.73 28022.66 27483.9360.33 7.49 (6.38–8.63) 120 (106–135) 32 (28–36) 18 (15–22) 11 (9–12)
GTR+C+I, strict clock 2549.27 28035.01 27485.7360.24 7.59 (6.48–8.80) 118 (105–133) 31 (27–34) 18 (15–22) 11 (9–13)
Best-fit model is shown in bold. GTR+C4+I, General Time Reversible (GTR) substitution model with 4 categories of C plus invariable rates; 95% HPD, 95% highest
probability density; TMRCA, time to the most recent common ancestor; AM/AS, American/Asian.
doi:10.1371/journal.pone.0027459.t002
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TMRCA existed about 11 years ago (95% HPD: 9–12) (Table 2).
The BS analysis shows a sharp increase in the diversity that
started around 1997–1998, coinciding with the large epidemic
caused by DENV-1 and DENV-2 in Nicaragua in 1998 [10,28],
after a period of genetic stability from 1983 to 1997. This diversity
reached a plateau that remained steady until the end of 2001,
when the genetic diversity of the virus came down quickly to the
same levels observed before 1996. That low diversity was
maintained until 2003. Around the end of 2003 and the beginning
of 2004 another sharp increase in diversity occurred reaching
higher levels of genetic variability than those observed before,
peaking around 2006. That trend was sustained until 2009, the last
year sampled in our study. The observed high genetic diversity in
circulating DENV-2 in Central American together with the results
from our phylogenetic analysis, suggest that the virus is undergoing
evolution in situ. That together with the geographical expansion of
emerging clades of the virus may result in an increased number of
cases of severe dengue in the countries of the region.
Discussion
We analyzed the phylogenetic relationships of DENV-2 strains
isolated from countries of Central America from 1999 to 2009. To
the best of our knowledge, this is the first report on the phylogeny,
molecular clock and selection pressure analysis of DENV-2 in this
region. We also report here the first complete genome sequence of
a Guatemalan DENV strain, and the second DENV-2 ever
sequenced from that country. Our phylogenetic analysis suggests
that two lineages of DENV-2 of AM/AS genotype have circulated
in Central America and in Nicaragua, they have co-circulated at a
certain point in the recent past.
An inherent limitation of this analysis is the fact that most
sequences of DENV-2 strains from Central America available in
the GenBank are from Nicaragua. Only a very small number of
sequences available are from the rest of the countries of Central
America, and those are mostly partial sequences. Thus, additional
fully sequenced strains of DENV from other countries of Central
America are needed in order to perform analyses to better
Figure 3. Maximum clade credibility (MCC) tree and Bayesian Skyline plot of the analyzed DENV-2. A) Bayesian coalescent inference of
genetic diversity and population dynamics using the Bayesian Skyline plot available in BEAST 1.6.1., for DENV-2 strains of American/Asian genotype in
Central America. X axis represents years of study and y axis the relative genetic diversity product of the effective population size. Black line represents
the mean estimate and the blue shadow, the 95%HPD. B) Maximum clade credibility tree derived from the Bayesian analysis of the envelope protein
of DENV-2 with the best fit model (relaxed lognormal clock), showing the mean time to the most recent common ancestor (TMRCA) in each principal
node (mean and 95%HPD). The 95% highest probability density (95%HPD) for each node age, are shown as blue bars. DENV-2 genotypes (Sylvatic,
American, Asian I and II, Cosmopolitan and American/Asian) are identified. Clades 2a and 2b are highlighted in a green and red shadow, respectively.
doi:10.1371/journal.pone.0027459.g003
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DENV in that region.
The phylogeny of DENV-2 in Central America has been largely
hypothesized to be reflected by the Nicaraguan scenario, from
where an important number of sequences spanning more than a
decade of collections are available for study. The exact year in
which the AM/AS genotype of DENV-2 was introduced into
countries of Central America other than Nicaragua, and its
complete phylogenetic history is hard to trace due to the
unavailability of sequences spanning the last 15 years, time in
which that genotype started to replace all other genotypes in the
continent [2]. Data from our molecular clock analysis suggest the
TMRCA for the AM/AS genotype strains from Central America
existed around 19 years ago (95%HPD 15–22 years).
The first reference to the origin of Nicaraguan DENV-2 strains
was made during the epidemic of 1998, where Balmaseda et al
[28] using restriction site-specific PCR (RSS-PCR) identified the
isolates circulating as belonging to the ‘‘Jamaica’’ subtype (AM/AS
genotype). More recently within the Pediatric Dengue Cohort
Study (PDCS) conducted in that country since 2004, a number of
strains have been sequenced and phylogeographic analyses have
been conducted identifying two clades of DENV-2 circulating in
its capital city Managua. These clades, denominated ‘‘clade 1’’
and ‘‘clade 2’’ by Balmaseda [29], correspond respectively to
clades 2a and 2b in this study. One of these circulating clades
(‘‘clade 2’’ in Balmaseda’s nomenclature) has been associated with
severe dengue and also with the appearance of a higher proportion
of symptomatic dengue cases in the cohort during 2007-2008
[29,30]. In those studies, the authors suggest that the older ‘‘clade
1’’ circulated during 2004–2005 and 2005–2006 and ‘‘clade 2’’
was only found during 2006–2007 and 2007–2008. In our
analysis, we have found that a number of strains from 2004 and
2005 (therefore corresponding to their ‘‘clade 1’’) clustered
together with strains from 2007 and 2009 (Figures 1B and 2B).
That finding suggest that the co-circulation of both clades still
happened in later years, perhaps in lower frequency than before,
but in fact the new ‘‘clade 2’’ has not totally replaced ‘‘clade 1’’ in
Nicaragua. In our analysis, the TMRCA for clade 2b (that
includes strains from Nicaragua, Honduras and Guatemala)
appears between 9 and 12 years ago (mean 11 years), coinciding
with the occurrence of large DENV epidemics associated with
circulation of DENV-2 with any of the other serotypes in the
countries of that region [10].
While in Nicaragua strains from this AM/AS genotype has been
linked to severe dengue, this has not been the case in other
countries of that region [10,29]. However, the low number of cases
of severe dengue reported in Belize, Costa Rica, El Salvador,
Guatemala, and Panama most likely result from under-reporting
or misdiagnosis, which have been proven to occur in other dengue
endemic countries in the Americas [31]. On the other hand,
Honduras is by far the country that has reported more cases of
dengue, dengue hemorrhagic fever/severe dengue and deaths
associated with the disease in Central America in the last decade
(Figures S1, S2, and S3). Interestingly, it may have happened that
opposed to other Central American countries that may have been
underreporting, in Honduras cases of other febrile diseases may
have been accounted as dengue cases, which were most likely not
confirmed by laboratory tests. Consequently, the number of
symptomatic dengue cases in that country may be over reported.
This interesting epidemiological question deserves to be studied in
more detail.
Another limitation encountered when performing such epide-
miological analyses in that the official statistics available from
PAHO, which are received directly from the Ministries of Health
from the countries of the region, sometimes reflects the number of
suspected dengue cases while in others refer to confirmed cases
only, as is the case of Nicaragua [10]. Even in the case of
Nicaragua, recent reports show significant differences in the
number of confirmed symptomatic dengue cases obtained in the
PDSC study in comparison with data provided by the Nicaraguan
Ministry of Health, which is used as source for the official statistics
compiled by the PAHO [32].
Central America represents an interesting place to the
evolutionary dynamic of dengue. The region is surrounded by
the Caribbean and South America, both of which have been
continuous foci of dengue transmission in the last decades
[2,8,14,26]. DENV-2 strains from Asian origin have replaced
the autochthonous AM strains that were circulating in the region
during the 80s and 90s [5]. This has been linked, at least in a part,
to the increasing number of severe dengue cases reported in the
continent [13,33].
Circulation of DENV-2 strains from three genotypes and its
ultimate replacement by strains of the AM/AS genotype has been
reported in Central America. Bennet et al. [2] reports phyloge-
netic analyses that includes a number of Central American strains
of the AS-I genotype (strain ES 12 00 from El Salvador), AM
genotype (strains CR A and B from Costa Rica) and the AM/AS
genotype (CR 6530/2000 and CR 7945/2000 from Costa Rica
and strain ES 18 99/1999 from El Salvador). All these AM/AS
genotype sequences were included in our E protein gene
phylogenetic analysis. Similarly, Foster et al [8] found four
Honduran strains from 1991 (HON A–D) and a single strain from
El Salvador (SAL 1987) belonging to the AM genotype, while a
single Honduran strain (HON 1986) was identified to be closely
related with the prototype strain New Guinea C (NGC), from the
AS-II genotype.
Circulation of strains of the AS-I or AS-II genotypes in the
Americas has been previously reported in countries outside
Central America (Venezuela, Cuba, Haiti and Mexico)
[13,26,34,35]. However, that seems to be unlikely and possibly
the resultant of laboratory contamination with the strain NGC, a
commonly used prototype strain present in most of the
laboratories involved in dengue research throughout the world.
Cases of NGC-like strains have been detected and reported even
in different regions outside the Americas (i.e. China and Vietnam
[26]), but none of these NGC-like strains have the amount of
variation expected based on the consistently reported substitution
rates to which epidemic DENV-2 would be subjected in nature
[8,36]. On the other hand, a single strain isolated in 1996 (strain
BC17) from the Mexican state of Yucatan which is a neighbor of
Guatemala, has been reported to cluster within the COS genotype
[34]. That finding has been considered as evidence of limited
circulation of this genotype in that region, although as in the case
of the strains of AS-I and AS-II genotypes identified circulating in
the continent, it may also be the result of erroneous identity and
potential contamination.
Our analysis shows that strains GU/FDA-GUA09/2009 and
HN/F07-075/2007 constitute a different lineage within sub-clade
2b of the AM/AS genotype of DENV-2. This finding is supported
by high bootstrap values in ML analysis and Bayesian high
posterior probability values. Thus, our analysis confirmed that this
linage of the AM/AS genotype represented by GU/FDA-
GUA09/2009 and HN/F07-075/2007 strains, circulated in
2009 in Guatemala. These findings agree with the suggestion by
Tang et al. [37] that the strains currently present in Guatemala
and Honduras may be the result of re-emergence of autochtho-
nous DENV-2 strains introduced sometime in the past, instead of
being newly introduced viruses. If this is true, it is possible to
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circulating in these countries, and that idea can be supported by
our results that also identified at least two lineages of DENV-2
circulating simultaneously in neighboring Nicaragua. There is a
possibility suggested by the positioning of strain NI/BID-V2924/
2000 basal to clade 2b (Figures 1B and 2B) that in the past, strains
closely related to NI/BID-V2924/2000 were introduced from
Nicaragua to neighboring Guatemala and Honduras, and that
continuous introduction resulted in clade replacement by strains
with higher fitness, followed by in situ evolution of these lineages.
This may be an epidemiological feature of DENV-2 transmission
dynamics in Central America.
In relation to the selection pressure exerted over DENV-2, a
number of reports [25,38] and our own results shown that overall
the amino acid sequences in DENV-2 are highly conserved,
therefore suggesting that the virus is subjected to strong purifying
selection. However, in our analysis we were able to detect codons
under weak positive selection in the Central American DENV-2
strains analyzed: two when analyzing E protein gene datasets
alone (codons 83 and 131) and nine when analyzing ORF datasets
(codons C41,E 83 and 129, NS2A2, NS3180 and 437, NS5269, 523 and
850) (Table 1).
The findings of positive selection in codons of E are expected
since this protein is subjected to immune pressure and a number of
codons in E have been reported to be subjected to this type of
selection. From the three codons found under positive selection in
the Central America datasets used in our analysis two (129 and
131) have been reported before by Twiddy et al and Bennet et al
[2,26,39] when analyzing datasets of Cosmopolitan, Asian and
AM/AS DENV-2 strains, but codon 83 identified by our analysis
appears to be a novel addition to the already numerous sites
identified under positive pressure in the E protein gene to date
(reviewed in [27]). In congruence with Vasilakis et al. [25], we did
not find evidence of positive selection on E protein position 390,
which has been suggested as a virulence marker for DENV-2 [33].
However, we found that the mutation DRN390 was fixed in all the
analyzed DENV-2 strains from Central America since 1999 (G.
An ˜ez, information not published).
We also detected for the first time positive selection in a codon of
the capsid of the virus (C41), close to the hydrophobic conserved
region of the protein [40], although only when using the IFEL
method and very close to the statistical significant threshold. The
capsid of DENV contains the genome viral, and no site under
positive pressure had been reported for any of the DENV serotypes
to date. However, it may be possible that in the in situ evolution
scenario that the AM/AS genotype of DENV-2 is undergoing in
Central America, viruses with amino acids residues responsible for
advantageous replication are been selected in this protein, and that
the role of the adaptive pressure over this site in the capsid protein
needs to be properly addressed by detailed studies.
We are also reporting for the first time all sites detected by our
analyses under positive pressure in the NS2A, NS3 and NS5 genes.
Since the function of the small NS2A protein is not well understood,
it is hard to speculate about the significance of codons found under
positive pressure in this protein. NS2A, NS4A and NS4B has been
shown to antagonize the interferon response during DENV
infection [41], and it would be evolutionary advantageous for the
virus to select for strains with strong innate immunity suppression
mechanisms. As for the sites detected in NS3, there have not been
reports on positive selection in this protein in none of DENV
serotypes before. NS3 is important protein for the replication of the
virus, since it possesses protease and ATPase/helicase functions
necessary for viral replication [42], and as in the case of the capsid
protein, this finding needs to be further investigated.
Three codons were identified under positive pressure in the NS5
protein, which is crucial for viral replication for its RNA-
dependent RNA polymerase [43]. All these sites were detected
only by one of the methods employed, except for one site (NS5523)
that was detected by both FEL and the IFEL methods in both
ORF datasets. In the case of the other two sites reported in the
NS5 protein (269 and 850), these sites were detected by either one
of the methods (FEL and IFEL) with statistical significance, while p
values from the other method were very close to the established
significance limits (Table 1). Jointly, these results should be studied
in greater detail to elucidate the possible role of these residues in
the pathogenesis of the disease.
Nucleic acid amplification technology (NAT) assays has been
developed and implemented in the detection of DENV in endemic
countries, as well as in places in which the disease is imported and
can cause autochthonous transmission, as it happened recently in
the US [44]. Even though primers and probes for these assays are
designed to target conserved regions of the viral genome, there is
always a risk that the assay could fail to detect variants bearing
mutations located at the target area. Monitoring of the occurrence
of mutations in DENV appears to be a solution that allows for
updating diagnostic NAT assays when needed. The use of
complete genome sequencing appears to be more suitable than
partial sequencing in order to detect variations that could appear
all over the DENV genome and could negatively affect the
performance of NAT tests.
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